Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Begin your investing journey with these value investing tips for beginners. Learn how to identify great stocks at bargain prices.
20,217 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...
Micron Technology posted a strong quarter but faced a sharp pullback as investors priced in a tougher near-term path....
Grief arrives for anyone, but when the world watches, money and plans can unravel faster than a headline. This piece ...
In 2026, the crypto market offers many opportunities, but not all are worth your money. This guide explains why a sin...
VOO has delivered outsized gains over the last decade, returning 281% over years. Yet a heavy tilt to mega-cap tech a...
Megapot has secured $5 million in a Dragonfly-led round to scale a crypto-powered global lottery. The platform now se...
CrowdStrike delivered a solid ARR beat but guided below lofty expectations, triggering a about 7% drop in CRWD shares...
Meta has slashed about 25,000 jobs since 2022, with 700 more in Reality Labs this week. The moves spotlight a leaders...
As 2026 unfolds, investors eye the best blockchain penny stocks for upside amid renewed crypto infrastructure gains. ...
United Wholesale Mortgage announces a free 1-0 temporary rate buydown on purchase loans and introduces a new home equ...
Goldman Sachs' latest research paints a paradox: trillions are pouring into AI infrastructure, but returns remain mur...